Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, a synthetic peptide used in the treatment of type 2 diabetes, weight management,… Read more











![Chemical structure of [D-Ala21]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Ala21-Tirzepatide.png&w=3840&q=75)
![Chemical structure of [D-Ala35]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Ala35-Tirzepatide.png&w=3840&q=75)
![Chemical structure of [Des-Gly30]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDes-Gly30-Tirzepatide.png&w=3840&q=75)
![Chemical structure of [Des-Gly34]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDes-Gly34-Tirzepatide.png&w=3840&q=75)
![Chemical structure of [Kyn25]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FKyn25-Tirzepatide.png&w=3840&q=75)
![Chemical structure of [Nva12]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FNva12-Tirzepatide.png&w=3840&q=75)





![Chemical structure of Des-[Gly(30)-Pro(31)]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDes-Gly30-Pro31-Tirzepatide.png&w=3840&q=75)




![Chemical structure of Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2460751-66-8-Fmoc-L-LysC20-OtBu-GluOtBu-AEEA-AEEA-OH.png&w=3840&q=75)

![Chemical structure of Fragment [1-24]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FFragment-1-24-Tirzepatide.png&w=3840&q=75)


![Chemical structure of Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2931515-16-9-LysC20-OtBu-GluOtBu-AEEA-AEEA-OH.png&w=3840&q=75)








![Chemical structure of Val-[12]-Tirzepatide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FVal-12-Tirzepatide.png&w=3840&q=75)
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, a synthetic peptide used in the treatment of type 2 diabetes, weight management, and obstructive sleep apnea. This category contains a comprehensive range of reference standards, including the active pharmaceutical ingredient, its degradation products, and specific process-related impurities. Pharmaceutical laboratories utilize these materials for essential quality control procedures, such as impurity profiling and the validation of stability-indicating analytical methods. By providing highly characterized compounds, these standards enable researchers to accurately identify and quantify trace substances within the drug matrix, ensuring adherence to regulatory requirements. Additionally, the inclusion of stable isotope labelled compounds facilitates advanced analytical characterization and precise quantification in complex bioanalytical studies, such as pharmacokinetics and mass spectrometry-based assays, ultimately supporting the development and safety of this therapeutic agent.